Implementation and assessment of a medication therapy management program in HIV patients at high risk of adverse drug events in Khartoum Sudan

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN76092134

Enrollment

1140

Registered

2026-02-16

Start date

2022-01-10

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

To implement and assess a medication therapy management program and studying the positive impacts on medication safety, adherence, and patient satisfaction for HIV patients at high risk of ADEs in Khartoum, Sudan Other

Interventions

MTM Program Development The MTM intervention is developed based on established pharmaceutical care principles, international MTM guidelines, and adaptation to the Sudanese healthcare context [18,19].

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. HIV-positive individuals aged 18 years and older. 2. Primary use of English or Arabic for oral and written communication. 3. =3 comorbid conditions associated with increased healthcare utilization (e.g., CHF, DM, COPD, HTN, opportunistic infections). 4. =2 visits to a physician or advanced practice provider at the study site clinic over the past year. 5. =8 chronic prescription medications over the 6 months prior to study enrollment. 6. Have a telephone line available for at least 6 months. 7. Willingness to participate in the study and provide informed consent. 8. Situation placing the patient at risk for a drug-related problem (DRP): Change in medication, new physician visit, ER visit, hospitalization, invasive procedure within the last 30 days, or seeing 3 or more providers within 12 months. Part 2: MTM Provider (Pharmacist Population) 1. Pharmacists involved in delivering MTM services to HIV patients. 2. At least six months of experience providing MTM services to HIV patients.

Exclusion criteria

Exclusion criteria: 1. Terminal condition with life expectancy =6 months 2. Previous enrolment in the MTM program with medication reconciliation or assessment for DRPs within 12 months 3. Inability to provide informed consent or participate in the study due to cognitive impairment or other reasons

Countries

Sudan

Contacts

Public ContactNada abdelrahman Ibrahim

nadaaboras@student.usm.my+966 596056088

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 14, 2026